Trevi Therapeutics：A Chronic Cough Pipeline in a Product

A Chronic Cough Pipeline in a Product

Haduvio™(oralnalbuphineER)isacentrallyandperipherallyactinginvestigationaltherapywhichwearecurrentlydevelopingforthetreatmentofpatients ...。其他文章還包含有：「TreviTherapeutics(」、「TreviTherapeuticsReportsFirstQuarter2024Financial...」、「TreviTherapeutics」、「TreviTherapeutics,Inc.(TRVI)StockPrice」、「TreviTherapeutics」、「TreviTherapeutics」、「TRVI-TreviTherapeutics,Inc.」

查看更多離開網站

Provide From Google

Trevi Therapeutics (

https://twitter.com

Trevi is a clinical-stage biopharma company currently developing the investigational oral therapy Haduvio™ (nalbuphine ER) for serious chronic cough conditions.

Provide From Google

Trevi Therapeutics Reports First Quarter 2024 Financial ...

https://www.prnewswire.com

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for ...

Provide From Google

Trevi Therapeutics

https://tw.linkedin.com

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the ...

Provide From Google

Trevi Therapeutics, Inc. (TRVI) Stock Price

https://finance.yahoo.com

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment ...

Provide From Google

Trevi Therapeutics

https://hk.finance.yahoo.com

TRVI - Trevi Therapeutics, Inc. NasdaqGM - NasdaqGM 即時價格。貨幣為USD。 Trevi Therapeutics, Inc. 195 Church Street 16th Floor New Haven, CT 06510. United ...

Provide From Google